Most up-to-date research on "Dermatology Partnering Terms and Agreements" to its huge collection of research reports.
Albany, NY -- (SBWIRE) -- 01/08/2015 -- The Dermatology Partnering Terms and Agreementsreport provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals.
The majority of deals are marketed stage deals whereby the licensee obtains a marketing right or an option to co market or market the licensors dermatology product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Browse Detail Report With TOC
This report provides details of the latest dermatology deals and contracts announced in the healthcare sectors.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
The report includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates.
The initial chapters of this report provide an orientation of dermatology dealmaking and business activities.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in dermatology dealmaking since 2009 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.
Chapter 3 provides a review of the leading dermatology deals since 2009. Deals are listed by headline value, signed by bigp harma and big biotech and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapters 4 and 5 provide a comprehensive listing of the top 50 big pharma and big biotech companies with a brief summary followed by a comprehensive listing of dermatology deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 6 provides comprehensive access to all dermatology deals since 2009 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.
Chapter 7 provides a comprehensive directory of all dermatology partnering deals by specific therapeutic target announced since 2009. The chapter is organized by specific dermatology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2009. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
For Market Research Latest Reports Visit
The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2009.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.
Dermatology Partnering Terms and Agreementsprovides the reader with the following key benefits:
In-depth understanding of dermatology deal trends since 2009
Access dermatology deal headline, upfront, milestone and royalty data
Research hundreds of actual contracts between dermatology partner companies
Comprehensive access to over 750 links to actual dermatology deals entered into by the world's biopharma companies
Indepth review of dermatology deals entered into by the leading fifty bigpharma companies
Benchmark the key deal terms companies have agreed in previous deals
Identify key terms under which companies partner dermatology opportunities
Uncover companies actively partnering dermatology opportunities
Dermatology Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to dermatology trends and structure of deals entered into by leading companies worldwide.
Dermatology Partnering Terms and Agreements includes:
Trends in dermatology dealmaking in the biopharma industry since 2009
Analysis of dermatology deal structure
Access to headline, upfront, milestone and royalty data
Access to hundreds of dermatology deal contract documents
Comprehensive access to over 750 dermatology deal records
The leading dermatology deals by value since 2009
Most active dermatology dealmakers since 2009
In Dermatology Partnering Terms and Agreements, available deals and contracts are listed by:
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Specific therapy indication
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Global and China Serum Protein Industry 2015 Market Research Report
For overview analysis, the report introduces Serum protein basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Serum protein markets in China and other countries or regions (such as US, Europe, Japan, etc) by...
CytomX Therapeutics, Inc. - Product Pipeline Review - 2014
CytomX Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Directs, CytomX Therapeutics, Inc. - Product Pipeline Review - 2014, provides an overview of the CytomX Therapeutics, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of CytomX Therapeutics, Inc.s, complete with...
For More Reports Browse
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact: